Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01351766 · ClinicalTrials.gov registry record · Phase 3
Behavioral Activation Intervention, Reward Processing, and Youth Smoking Cessation
A Phase 3 study, sponsored by University of Maryland, College Park.
- Completed
- Registry status
- Phase 3
- Development phase
- 39
- Enrollment target
NCT01351766 is a Phase 3 study that has completed, run by University of Maryland, College Park. The registered enrollment target is 39 participants.
The verdict
NCT01351766, a Phase 3 study, has completed, sponsored by University of Maryland, College Park.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 39 participants
- Enrollment target
Study Summary
The primary purpose of this study is to develop a specialized behavioral activation treatment for smoking in youths ages 18-21 with elevated depressive symptoms. In the first phase we utilize focus groups and pilot testing with 15 youths to develop the behavioral activation smoking treatment for youth. In Phase II, we will conduct an open-label trial of the new treatment that will include 8 weeks of transdermal nicotine patch, which will begin at the time of quitting smoking. Participants will be followed over 26 weeks post-quit date. A subset of participants will also undergo an fMRI session to examine reward sensitivity.
Interventions
- DRUG Transdermal Nicotine Patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2010-04 |
| Est. Completion | 2013-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01351766
The ClinicalTrials.gov registry entry for NCT01351766 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, College Park, which has 46 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Transdermal Nicotine Patch is the first listed.
NCT01351766 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01351766 about?
NCT01351766 is a clinical study titled "Behavioral Activation Intervention, Reward Processing, and Youth Smoking Cessation". The primary purpose of this study is to develop a specialized behavioral activation treatment for smoking in youths ages 18-21 with elevated depressive symptoms. In the first phase we utilize focus groups and pilot testing with 15 youths to develop the behavioral activation smoking treatment for you...
What is the current status of trial NCT01351766?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 39 participants. The study started on 2010-04. Estimated completion is 2013-05.
What interventions are being tested in trial NCT01351766?
The interventions under investigation include: Transdermal Nicotine Patch (DRUG).
Who is sponsoring clinical trial NCT01351766?
This trial is sponsored by University of Maryland, College Park, which has 46 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.